世界のヒト白血球抗原検査市場予測（～2028年）：分子アッセイ技術、非分子アッセイ技術

• 英文タイトル：Global Human Leukocyte Antigen Testing Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E7965 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ヒト白血球抗原検査市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のヒト白血球抗原検査の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ヒト白血球抗原検査市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・分子アッセイ技術、非分子アッセイ技術 用途別セグメントは次のように区分されます。 ・独立参考検査室、病院＆移植センター、研究所＆学術機関 世界のヒト白血球抗原検査市場の主要な市場プレーヤーは以下のとおりです。 ・Thermo Fisher Scientific、F. Hoffman-La Roche、Bio-Rad Laboratories、QIAGEN N.V.、Illumina、Immucor、CareDx、Becton Dickinson、Hologic、GenDx、Biofortuna 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ヒト白血球抗原検査製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なヒト白血球抗原検査メーカーの企業概要、2019年～2022年までのヒト白血球抗原検査の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なヒト白血球抗原検査メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ヒト白血球抗原検査の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのヒト白血球抗原検査の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒト白血球抗原検査市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびヒト白血球抗原検査の産業チェーンを掲載しています。 ・第13、14、15章では、ヒト白血球抗原検査の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Thermo Fisher Scientific、F. Hoffman-La Roche、Bio-Rad Laboratories、QIAGEN N.V.、Illumina、Immucor、CareDx、Becton Dickinson、Hologic、GenDx、Biofortuna ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：分子アッセイ技術、非分子アッセイ技術 ・用途別分析2017年-2028年：独立参考検査室、病院＆移植センター、研究所＆学術機関 ・ヒト白血球抗原検査の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・ヒト白血球抗原検査のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヒト白血球抗原検査のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヒト白血球抗原検査の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・ヒト白血球抗原検査の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Human Leukocyte Antigen Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Leukocyte Antigen Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Independent Reference Laboratories accounting for % of the Human Leukocyte Antigen Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Molecular Assay Technologies segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Leukocyte Antigen Testing include Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., and Illumina, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Leukocyte Antigen Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Molecular Assay Technologies
Non-molecular Assay Technologies
Market segment by Application can be divided into
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
The key market players for global Human Leukocyte Antigen Testing market are listed below:
Thermo Fisher Scientific
F. Hoffman-La Roche
Bio-Rad Laboratories
QIAGEN N.V.
Illumina
Immucor
CareDx
Becton Dickinson
Hologic
GenDx
Biofortuna
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Leukocyte Antigen Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Leukocyte Antigen Testing, with price, sales, revenue and global market share of Human Leukocyte Antigen Testing from 2019 to 2022.
Chapter 3, the Human Leukocyte Antigen Testing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Leukocyte Antigen Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Leukocyte Antigen Testing market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Leukocyte Antigen Testing.
Chapter 13, 14, and 15, to describe Human Leukocyte Antigen Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Human Leukocyte Antigen Testing Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Leukocyte Antigen Testing Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Molecular Assay Technologies
1.2.3 Non-molecular Assay Technologies
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Leukocyte Antigen Testing Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Independent Reference Laboratories
1.3.3 Hospitals & Transplant Centers
1.3.4 Research Laboratories & Academic Institutes
1.4 Global Human Leukocyte Antigen Testing Market Size & Forecast
1.4.1 Global Human Leukocyte Antigen Testing Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Leukocyte Antigen Testing Sales in Volume (2017-2028)
1.4.3 Global Human Leukocyte Antigen Testing Price (2017-2028)
1.5 Global Human Leukocyte Antigen Testing Production Capacity Analysis
1.5.1 Global Human Leukocyte Antigen Testing Total Production Capacity (2017-2028)
1.5.2 Global Human Leukocyte Antigen Testing Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Leukocyte Antigen Testing Market Drivers
1.6.2 Human Leukocyte Antigen Testing Market Restraints
1.6.3 Human Leukocyte Antigen Testing Trends Analysis
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Human Leukocyte Antigen Testing Product and Services
2.1.4 Thermo Fisher Scientific Human Leukocyte Antigen Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 F. Hoffman-La Roche
2.2.1 F. Hoffman-La Roche Details
2.2.2 F. Hoffman-La Roche Major Business
2.2.3 F. Hoffman-La Roche Human Leukocyte Antigen Testing Product and Services
2.2.4 F. Hoffman-La Roche Human Leukocyte Antigen Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories Human Leukocyte Antigen Testing Product and Services
2.3.4 Bio-Rad Laboratories Human Leukocyte Antigen Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 QIAGEN N.V.
2.4.1 QIAGEN N.V. Details
2.4.2 QIAGEN N.V. Major Business
2.4.3 QIAGEN N.V. Human Leukocyte Antigen Testing Product and Services
2.4.4 QIAGEN N.V. Human Leukocyte Antigen Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business
2.5.3 Illumina Human Leukocyte Antigen Testing Product and Services
2.5.4 Illumina Human Leukocyte Antigen Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Immucor
2.6.1 Immucor Details
2.6.2 Immucor Major Business
2.6.3 Immucor Human Leukocyte Antigen Testing Product and Services
2.6.4 Immucor Human Leukocyte Antigen Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 CareDx
2.7.1 CareDx Details
2.7.2 CareDx Major Business
2.7.3 CareDx Human Leukocyte Antigen Testing Product and Services
2.7.4 CareDx Human Leukocyte Antigen Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Becton Dickinson
2.8.1 Becton Dickinson Details
2.8.2 Becton Dickinson Major Business
2.8.3 Becton Dickinson Human Leukocyte Antigen Testing Product and Services
2.8.4 Becton Dickinson Human Leukocyte Antigen Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Hologic
2.9.1 Hologic Details
2.9.2 Hologic Major Business
2.9.3 Hologic Human Leukocyte Antigen Testing Product and Services
2.9.4 Hologic Human Leukocyte Antigen Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 GenDx
2.10.1 GenDx Details
2.10.2 GenDx Major Business
2.10.3 GenDx Human Leukocyte Antigen Testing Product and Services
2.10.4 GenDx Human Leukocyte Antigen Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Biofortuna
2.11.1 Biofortuna Details
2.11.2 Biofortuna Major Business
2.11.3 Biofortuna Human Leukocyte Antigen Testing Product and Services
2.11.4 Biofortuna Human Leukocyte Antigen Testing Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Leukocyte Antigen Testing Breakdown Data by Manufacturer
3.1 Global Human Leukocyte Antigen Testing Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Leukocyte Antigen Testing Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Leukocyte Antigen Testing
3.4 Market Concentration Rate
3.4.1 Top 3 Human Leukocyte Antigen Testing Manufacturer Market Share in 2021
3.4.2 Top 6 Human Leukocyte Antigen Testing Manufacturer Market Share in 2021
3.5 Global Human Leukocyte Antigen Testing Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Leukocyte Antigen Testing Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Leukocyte Antigen Testing Market Size by Region
4.1.1 Global Human Leukocyte Antigen Testing Sales in Volume by Region (2017-2028)
4.1.2 Global Human Leukocyte Antigen Testing Revenue by Region (2017-2028)
4.2 North America Human Leukocyte Antigen Testing Revenue (2017-2028)
4.3 Europe Human Leukocyte Antigen Testing Revenue (2017-2028)
4.4 Asia-Pacific Human Leukocyte Antigen Testing Revenue (2017-2028)
4.5 South America Human Leukocyte Antigen Testing Revenue (2017-2028)
4.6 Middle East and Africa Human Leukocyte Antigen Testing Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Leukocyte Antigen Testing Sales in Volume by Type (2017-2028)
5.2 Global Human Leukocyte Antigen Testing Revenue by Type (2017-2028)
5.3 Global Human Leukocyte Antigen Testing Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Leukocyte Antigen Testing Sales in Volume by Application (2017-2028)
6.2 Global Human Leukocyte Antigen Testing Revenue by Application (2017-2028)
6.3 Global Human Leukocyte Antigen Testing Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Leukocyte Antigen Testing Sales by Type (2017-2028)
7.2 North America Human Leukocyte Antigen Testing Sales by Application (2017-2028)
7.3 North America Human Leukocyte Antigen Testing Market Size by Country
7.3.1 North America Human Leukocyte Antigen Testing Sales in Volume by Country (2017-2028)
7.3.2 North America Human Leukocyte Antigen Testing Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Leukocyte Antigen Testing Sales by Type (2017-2028)
8.2 Europe Human Leukocyte Antigen Testing Sales by Application (2017-2028)
8.3 Europe Human Leukocyte Antigen Testing Market Size by Country
8.3.1 Europe Human Leukocyte Antigen Testing Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Leukocyte Antigen Testing Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Leukocyte Antigen Testing Sales by Type (2017-2028)
9.2 Asia-Pacific Human Leukocyte Antigen Testing Sales by Application (2017-2028)
9.3 Asia-Pacific Human Leukocyte Antigen Testing Market Size by Region
9.3.1 Asia-Pacific Human Leukocyte Antigen Testing Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Leukocyte Antigen Testing Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Leukocyte Antigen Testing Sales by Type (2017-2028)
10.2 South America Human Leukocyte Antigen Testing Sales by Application (2017-2028)
10.3 South America Human Leukocyte Antigen Testing Market Size by Country
10.3.1 South America Human Leukocyte Antigen Testing Sales in Volume by Country (2017-2028)
10.3.2 South America Human Leukocyte Antigen Testing Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Leukocyte Antigen Testing Sales by Type (2017-2028)
11.2 Middle East & Africa Human Leukocyte Antigen Testing Sales by Application (2017-2028)
11.3 Middle East & Africa Human Leukocyte Antigen Testing Market Size by Country
11.3.1 Middle East & Africa Human Leukocyte Antigen Testing Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Leukocyte Antigen Testing Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Leukocyte Antigen Testing and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Leukocyte Antigen Testing
12.3 Human Leukocyte Antigen Testing Production Process
12.4 Human Leukocyte Antigen Testing Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Leukocyte Antigen Testing Typical Distributors
13.3 Human Leukocyte Antigen Testing Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---